217730 — Kang Stem Biotech Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Market Cap
KR₩130bn
Enterprise Value
KR₩120bn
Revenue
KR₩8bn

Annual balance sheet for Kang Stem Biotech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	37,633	56,568	36,669	37,356	18,267
Net Total Accounts Receivable
Net Total Receivables	1,657	2,831	3,672	4,266	7,289
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	44,751	65,355	45,907	47,366	28,528
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	34,794	34,126	31,265	29,572	19,299
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	82,505	103,148	80,592	81,253	55,986
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12,206	22,473	19,709	24,199	7,732
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	30,886	35,075	31,222	33,242	12,804
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	51,620	68,073	49,370	48,012	43,182
Total Liabilities & Shareholders' Equity	82,505	103,148	80,592	81,253	55,986
Total Common Shares Outstanding
Total Preferred Shares Outstanding